Skip to main content
Clinical Trials/NCT02412774
NCT02412774CompletedNot Applicable

Effects of Replacing Diet Beverages With Water on Type 2 Diabetic Obese Females Attending a Weight Loss Program - a Randomized, 24 Week Clinical Trial

Novindiet Clinic2 sites in 2 countries81 target enrollmentStarted: April 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
81
Locations
2
Primary Endpoint
Weight loss

Study Overview

Brief Summary

The purpose of the present study is to evaluate the effect of replacing diet beverages with water on weight loss and biochemical indicators for insulin sensitivity and cardiometabolic risk factors of diabetic obese and overweight female adults when they are in a multidisciplinary weight loss plan.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diabetic female patient with 6.5<H1AC<7.
  • Monotherapy with Metformin.
  • 18-45 years of age.
  • Body mass index (BMI) between 27-35 kg/ m².
  • Consume DBs regularly during their habitual diet.
  • Must be able to have moderate exercise.
  • Must be interested to have weight loss.

Exclusion Criteria

  • Participating in a research project involving weight loss or physical activity in the previous six months.
  • Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months.
  • Taking medication that could affect metabolism or change body weight.
  • Report heart problems, chest pain, and cancer within the last five years.
  • Unwilling to change intake of beverages during the study period.

Outcomes

Primary Outcomes

Weight loss

Time Frame: 24 weeks

Secondary Outcomes

  • HA1C(24 Weeks)
  • Fasting plasma glucose(24 weeks)
  • Waist circumference(24 weeks)
  • Lipid profiles(24 weeks)
  • BMI(24 Weeks)
  • Insulin resistance (HOMA)(24 weeks)

Investigators

Sponsor
Novindiet Clinic
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials